Clal Biotechnology Industries Release: Andromeda Announces That Further Data Analyses Support Primary Endpoint in Andromeda Biotech's Phase III Clinical Study
5/10/2012 10:15:06 AM
More...
|
Teva Pharmaceutical Industries Limited (TEVA), Clal Biotechnology Industries Raises Stake in Diabetes Treatment Developer, Andromeda; Teva and Clal to Invest $17.5 Million
6/14/2010 6:45:58 AM
More...
|
Yissum Ltd., Pontifax, and Clal Biotechnology Industries Invest $9 Million in Avraham Pharmaceuticals Ltd. to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's Disease
4/14/2010 6:40:38 AM
More...
|
Arte Ventures And Clal Biotechnology Industries Introduce A New Model For Biotech Investment Management
3/27/2006 1:08:30 PM
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Buys 19% Of Clal Biotechnology Industries For $19 Million
10/19/2005 5:09:17 PM
More...
|